Flexion Therapeutics Inc. (FLXN) NASDAQ
$9.12 (0.02) (-0.22%)
Market Cap: -
As of 11/18/21 04:00 PM EST. Market closed.
Flexion Therapeutics Inc. (FLXN)
NASDAQ
$9.12
(0.02) (-0.22%)
Market Cap: -
As of 11/18/21 04:00 PM EST. Market closed.
Add to Portfolio
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and ... read more
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Clayman
Full Time Employees
257
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$3.22M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Clayman
Full Time Employees
257
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$3.22M
Address
10 Mall Rd Ste 301, Massachusetts, Burlington, 01803-4131.
PRICE CHART FOR FLEXION THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.19
Previous Close
$9.14
Days Range
$9.12 - $9.23
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
50,321,366
Open
$9.19
Previous Close
$9.14
Days Range
$9.12 - $9.23
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
50,321,366
FINANCIAL STATEMENTS FOR FLEXION THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR FLEXION THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Stejbach Mark | Director | Nov 19, 2021 | Option Exercise | $8.50 | 12,631 | 107,364 | 0 | Nov 19, 2021, 10:20 AM |
| MILINAZZO ALAN | Director | Nov 19, 2021 | Option Exercise | $8.50 | 27,450 | 233,325 | 0 | Nov 19, 2021, 10:19 AM |
| MERRIFIELD C ANN | Director | Nov 19, 2021 | Option Exercise | $8.50 | 19,000 | 161,500 | 0 | Nov 19, 2021, 10:17 AM |
| Lukatch Heath | Director | Nov 19, 2021 | Option Exercise | $8.50 | 9,000 | 76,500 | 0 | Nov 19, 2021, 10:16 AM |
| Kwo Elizabeth | Director | Nov 19, 2021 | Option Exercise | $8.50 | 4,500 | 38,250 | 0 | Nov 19, 2021, 10:14 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 9,000 | 76,500 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 388,683 | 3,303,806 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 5,871 | 49,904 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 994,129 | 8,450,097 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 5,000 | 42,500 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 250 | 2,125 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 72,035 | 612,298 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 19,653 | 167,051 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 1,000 | 8,500 | 0 | Nov 19, 2021, 10:12 AM |
| COLELLA SAMUEL D | Director | Nov 19, 2021 | Option Exercise | $8.50 | 943 | 8,016 | 0 | Nov 19, 2021, 10:12 AM |
| Canute Scott A | Director | Nov 19, 2021 | Option Exercise | $8.50 | 9,000 | 76,500 | 0 | Nov 19, 2021, 10:10 AM |
| MAHAFFY PATRICK J | Director | Nov 19, 2021 | Option Exercise | $8.50 | 39,824 | 338,504 | 0 | Nov 19, 2021, 10:09 AM |
| Levine Mark S. | General Counsel | Nov 19, 2021 | Option Exercise | $8.50 | 133,486 | 1,134,631 | 0 | Nov 19, 2021, 10:08 AM |
| Muzikant Adam | Chief Business Officer | Nov 19, 2021 | Option Exercise | $8.50 | 103,666 | 881,161 | 0 | Nov 19, 2021, 10:06 AM |
| Wentworth Kerry | Chief Regulatory Officer | Nov 19, 2021 | Option Exercise | $8.50 | 140,843 | 1,197,166 | 0 | Nov 19, 2021, 10:04 AM |
| Wentworth Kerry | Chief Regulatory Officer | Nov 19, 2021 | Option Exercise | $8.50 | 6,000 | 51,000 | 0 | Nov 19, 2021, 10:04 AM |
| Layman Melissa | Chief Commercial Officer | Nov 19, 2021 | Option Exercise | $8.50 | 103,956 | 883,626 | 0 | Nov 19, 2021, 10:03 AM |
| Willwerth Christina | Chief Strategy Officer | Nov 19, 2021 | Option Exercise | $8.50 | 141,241 | 1,200,549 | 0 | Nov 19, 2021, 10:01 AM |
| DRISCOLL FREDERICK W | Chief Financial Officer | Nov 19, 2021 | Option Exercise | $8.50 | 30,680 | 260,780 | 0 | Nov 19, 2021, 10:00 AM |
| Andrews William T. | Chief Medical Officer | Nov 19, 2021 | Option Exercise | $8.50 | 34,250 | 291,125 | 0 | Nov 19, 2021, 09:58 AM |
| Clayman Michael D. | President and CEO | Nov 19, 2021 | Option Exercise | $8.50 | 388,683 | 3,303,806 | 0 | Nov 19, 2021, 09:56 AM |
| Clayman Michael D. | President and CEO | Nov 19, 2021 | Option Exercise | $8.50 | 24,600 | 209,100 | 0 | Nov 19, 2021, 09:56 AM |
| Clayman Michael D. | President and CEO | Nov 19, 2021 | Option Exercise | $8.50 | 373,769 | 3,177,037 | 0 | Nov 19, 2021, 09:56 AM |
| Clayman Michael D. | President and CEO | Nov 19, 2021 | Option Exercise | $8.50 | 335,498 | 2,851,733 | 0 | Nov 19, 2021, 09:56 AM |
| Willwerth Christina | Chief Strategy Officer | Jul 19, 2021 | Sale | $6.45 | 3,945 | 25,445 | 141,241 | Jul 20, 2021, 08:51 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jul 19, 2021 | Sale | $6.45 | 3,944 | 25,439 | 140,362 | Jul 20, 2021, 08:49 PM |
| Muzikant Adam | Chief Business Officer | Jul 19, 2021 | Sale | $6.45 | 1,870 | 12,061 | 103,666 | Jul 20, 2021, 08:48 PM |
| Levine Mark S. | General Counsel | Jul 19, 2021 | Sale | $6.45 | 3,945 | 25,445 | 133,486 | Jul 20, 2021, 08:45 PM |
| Muzikant Adam | Chief Business Officer | Jun 21, 2021 | Option Exercise | $7.78 | 2,081 | 16,190 | 105,536 | Jun 28, 2021, 06:13 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jun 21, 2021 | Option Exercise | $7.78 | 539 | 4,193 | 144,306 | Jun 28, 2021, 06:09 PM |
| Clayman Michael D. | President and CEO | Jun 21, 2021 | Option Exercise | $7.78 | 1,700 | 13,226 | 348,840 | Jun 28, 2021, 06:04 PM |
| Arkowitz David | Chief Financial Officer | May 10, 2021 | Sale | $7.23 | 2,229 | 16,116 | 220,719 | May 12, 2021, 05:06 PM |
| Layman Melissa | Chief Commercial Officer | Mar 15, 2021 | Sale | $11.80 | 4,520 | 53,336 | 103,956 | Mar 16, 2021, 05:11 PM |
| Layman Melissa | Chief Commercial Officer | Jan 28, 2021 | Sale | $12.55 | 2,624 | 32,931 | 88,376 | Jan 29, 2021, 08:19 PM |
| Clayman Michael D. | President and CEO | Jan 28, 2021 | Option Exercise | $12.37 | 8,776 | 108,559 | 266,901 | Jan 29, 2021, 08:17 PM |
| Muzikant Adam | Chief Business Officer | Jan 05, 2021 | Sale | $11.13 | 4,005 | 44,576 | 73,455 | Jan 07, 2021, 06:02 PM |
| KELLEY SCOTT | Chief Medical Officer | Jan 05, 2021 | Sale | $11.13 | 6,829 | 76,007 | 113,549 | Jan 07, 2021, 05:58 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jan 05, 2021 | Sale | $11.13 | 6,829 | 76,007 | 113,767 | Jan 07, 2021, 05:56 PM |
| Willwerth Christina | Chief Strategy Officer | Jan 05, 2021 | Sale | $11.13 | 6,602 | 73,480 | 115,186 | Jan 07, 2021, 05:55 PM |
| Levine Mark S. | General Counsel | Jan 05, 2021 | Sale | $11.13 | 6,829 | 76,007 | 107,431 | Jan 07, 2021, 05:52 PM |
| Arkowitz David | Chief Financial Officer | Jan 05, 2021 | Sale | $11.13 | 6,073 | 67,592 | 151,048 | Jan 07, 2021, 05:50 PM |
| MILINAZZO ALAN | Director | Jul 09, 2020 | Option Exercise | $2.20 | 18,450 | 40,500 | 22,950 | Jul 10, 2020, 04:06 PM |
| Arkowitz David | Chief Financial Officer | Jun 22, 2020 | Option Exercise | $10.83 | 1,303 | 14,111 | 118,371 | Jun 24, 2020, 04:21 PM |
| Clayman Michael D. | President and CEO | Jun 22, 2020 | Option Exercise | $10.83 | 1,303 | 14,111 | 66,260 | Jun 24, 2020, 04:18 PM |
| KELLEY SCOTT | Chief Medical Officer | Jun 22, 2020 | Option Exercise | $10.83 | 595 | 6,444 | 80,960 | Jun 24, 2020, 04:15 PM |
| Levine Mark S. | General Counsel | Jun 22, 2020 | Option Exercise | $10.83 | 1,023 | 11,079 | 75,510 | Jun 24, 2020, 04:12 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jun 22, 2020 | Option Exercise | $10.83 | 369 | 3,996 | 81,430 | Jun 24, 2020, 04:09 PM |
| Stejbach Mark | Director | May 26, 2020 | Buy | $9.75 | 2,051 | 19,997 | 2,051 | May 27, 2020, 04:14 PM |
| Clayman Michael D. | President and CEO | May 26, 2020 | Buy | $9.75 | 10,256 | 99,996 | 346,605 | May 27, 2020, 04:11 PM |
| Arkowitz David | Chief Financial Officer | May 07, 2020 | Sale | $10.88 | 2,413 | 26,253 | 117,068 | May 11, 2020, 04:11 PM |
| Willwerth Christina | Chief Strategy Officer | Oct 07, 2019 | Option Exercise | $13.98 | 1,002 | 14,008 | 66,167 | Oct 08, 2019, 04:29 PM |
| Wentworth Kerry | Chief Regulatory Officer | Oct 07, 2019 | Option Exercise | $13.98 | 1,002 | 14,008 | 53,394 | Oct 08, 2019, 04:27 PM |
| Clayman Michael D. | President and CEO | Oct 07, 2019 | Option Exercise | $13.98 | 4,402 | 61,540 | 82,647 | Oct 08, 2019, 04:25 PM |
| KELLEY SCOTT | Chief Medical Officer | Oct 07, 2019 | Option Exercise | $13.98 | 334 | 4,669 | 53,089 | Oct 08, 2019, 04:21 PM |
| Bodick Neil | Chief Scientific Officer | Oct 07, 2019 | Option Exercise | $13.98 | 1,346 | 18,817 | 104,004 | Oct 08, 2019, 04:19 PM |
| MAHAFFY PATRICK J | Director | Aug 29, 2019 | Option Exercise | $0.16 | 30,824 | 4,932 | 30,824 | Aug 29, 2019, 04:46 PM |
| Willwerth Christina | Chief Strategy Officer | Aug 13, 2019 | Option Exercise | $0.16 | 8,750 | 1,400 | 67,169 | Aug 14, 2019, 04:06 PM |
| COLELLA SAMUEL D | Director | Aug 08, 2019 | Buy | $10.74 | 2,000 | 21,480 | 45,333 | Aug 09, 2019, 04:05 PM |
| Clayman Michael D. | President and CEO | Aug 08, 2019 | Buy | $10.85 | 2,317 | 25,136 | 72,249 | Aug 08, 2019, 04:38 PM |
| Clayman Michael D. | President and CEO | Jun 21, 2019 | Option Exercise | $9.81 | 1,492 | 14,637 | 71,424 | Jun 24, 2019, 05:23 PM |
| Levine Mark S. | General Counsel | Jun 21, 2019 | Option Exercise | $9.81 | 1,213 | 11,900 | 46,273 | Jun 24, 2019, 04:14 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jun 21, 2019 | Option Exercise | $9.81 | 389 | 3,816 | 50,996 | Jun 24, 2019, 04:13 PM |
| KELLEY SCOTT | Chief Medical Officer | Jun 21, 2019 | Option Exercise | $9.81 | 2,152 | 21,111 | 53,423 | Jun 24, 2019, 04:11 PM |
| Arkowitz David | Chief Financial Officer | Jun 21, 2019 | Option Exercise | $9.81 | 2,152 | 21,111 | 91,576 | Jun 24, 2019, 04:10 PM |
| Arkowitz David | Chief Financial Officer | May 31, 2019 | Buy | $11.05 | 2,500 | 27,627 | 89,424 | Jun 03, 2019, 04:18 PM |
| MERRIFIELD C ANN | Director | May 23, 2019 | Buy | $12.64 | 8,000 | 101,120 | 10,000 | May 24, 2019, 09:15 AM |
| Arkowitz David | Chief Financial Officer | May 13, 2019 | Buy | $11.99 | 4,000 | 47,960 | 86,924 | May 15, 2019, 04:05 PM |
| Clayman Michael D. | President and CEO | May 10, 2019 | Buy | $12.48 | 4,012 | 50,067 | 74,868 | May 13, 2019, 09:15 AM |
| Arkowitz David | Chief Financial Officer | May 08, 2019 | Sale | $10.06 | 2,248 | 22,615 | 82,924 | May 09, 2019, 04:32 PM |
| Clayman Michael D. | President and CEO | Mar 12, 2019 | Buy | $12.36 | 4,046 | 50,009 | 70,856 | Mar 13, 2019, 04:11 PM |
| Wentworth Kerry | Chief Regulatory Officer | Oct 08, 2018 | Option Exercise | $18.60 | 1,002 | 18,637 | 14,876 | Mar 05, 2019, 08:17 PM |
| Levine Mark S. | General Counsel | Jan 03, 2019 | Sale | $12.36 | 734 | 9,072 | 9,060 | Jan 04, 2019, 05:12 PM |
| Wentworth Kerry | Chief Regulatory Officer | Jan 03, 2019 | Sale | $12.36 | 622 | 7,688 | 11,207 | Jan 04, 2019, 05:10 PM |
| KELLEY SCOTT | Chief Medical Officer | Jan 03, 2019 | Sale | $12.36 | 622 | 7,688 | 15,271 | Jan 04, 2019, 05:09 PM |
| Arkowitz David | Chief Financial Officer | Dec 20, 2018 | Option Exercise | $10.48 | 922 | 9,663 | 49,172 | Jan 04, 2019, 05:07 PM |
| Bodick Neil | Chief Scientific Officer | Jan 03, 2019 | Sale | $12.36 | 746 | 9,221 | 64,782 | Jan 04, 2019, 05:06 PM |
| Clayman Michael D. | President and CEO | Jan 03, 2019 | Sale | $12.36 | 3,278 | 40,516 | 66,810 | Jan 04, 2019, 05:03 PM |
| Clayman Michael D. | President and CEO | Nov 09, 2018 | Buy | $17.10 | 5,000 | 85,477 | 69,166 | Nov 13, 2018, 09:17 AM |
| Arkowitz David | Chief Financial Officer | Nov 09, 2018 | Buy | $16.56 | 4,000 | 66,222 | 48,250 | Nov 13, 2018, 09:14 AM |
| Bodick Neil | Chief Scientific Officer | Oct 08, 2018 | Option Exercise | $18.60 | 1,345 | 25,017 | 65,528 | Oct 09, 2018, 05:08 PM |
| Clayman Michael D. | President and CEO | Oct 08, 2018 | Option Exercise | $18.60 | 6,233 | 115,934 | 83,849 | Oct 09, 2018, 04:31 PM |
| Wentworth Kerry | Chief Regulatory Officer | Oct 08, 2018 | Option Exercise | $18.60 | 1,002 | 18,637 | 11,476 | Oct 09, 2018, 04:30 PM |
| Arkowitz David | Chief Financial Officer | Aug 09, 2018 | Buy | $23.42 | 4,000 | 93,680 | 44,250 | Aug 10, 2018, 12:56 PM |
| Clayman Michael D. | President and CEO | Aug 09, 2018 | Buy | $22.33 | 10,000 | 223,300 | 75,282 | Aug 10, 2018, 09:13 AM |
| Bodick Neil | Chief Scientific Officer | Jul 02, 2018 | Sale | $25.10 | 33,508 | 841,192 | 78,799 | Jul 03, 2018, 12:00 AM |
| Bodick Neil | Chief Scientific Officer | Jul 03, 2018 | Sale | $25.00 | 16,492 | 412,300 | 62,307 | Jul 03, 2018, 12:00 AM |
| Wentworth Kerry | Chief Regulatory Officer | Jun 20, 2018 | Option Exercise | $21.22 | 171 | 3,629 | 12,478 | Jun 22, 2018, 04:37 PM |
| KELLEY SCOTT | Chief Medical Officer | Jun 20, 2018 | Option Exercise | $21.22 | 1,001 | 21,241 | 15,893 | Jun 22, 2018, 04:35 PM |
| Clayman Michael D. | President and CEO | Jun 20, 2018 | Option Exercise | $21.22 | 554 | 11,756 | 65,282 | Jun 22, 2018, 04:33 PM |
| Levine Mark S. | General Counsel | Jun 20, 2018 | Option Exercise | $21.22 | 539 | 11,438 | 8,872 | Jun 22, 2018, 04:30 PM |
| Bodick Neil | Chief Scientific Officer | May 11, 2018 | Option Exercise | $0.16 | 37,702 | 6,130 | 112,307 | May 11, 2018, 04:07 PM |
| Clayman Michael D. | President and CEO | Dec 20, 2017 | Option Exercise | $16.59 | 166 | 2,754 | 35,561 | Dec 22, 2017, 05:05 PM |
| KELLEY SCOTT | Chief Medical Officer | Dec 20, 2017 | Option Exercise | $16.59 | 858 | 14,234 | 6,559 | Dec 22, 2017, 04:59 PM |
| Bodick Neil | Chief Scientific Officer | Nov 21, 2017 | Buy | $24.66 | 1,000 | 24,656 | 1,000 | Nov 22, 2017, 05:28 PM |
| Bodick Neil | Chief Scientific Officer | Nov 21, 2017 | Buy | $24.39 | 1,700 | 41,457 | 64,605 | Nov 22, 2017, 05:28 PM |
| Clayman Michael D. | President and CEO | Nov 08, 2017 | Buy | $23.60 | 5,000 | 118,000 | 35,395 | Nov 09, 2017, 09:13 AM |
| Bodick Neil | Chief Scientific Officer | Oct 06, 2017 | Option Exercise | $29.93 | 1,598 | 47,835 | 62,905 | Oct 10, 2017, 04:43 PM |
| Clayman Michael D. | President and CEO | Oct 06, 2017 | Option Exercise | $29.93 | 5,794 | 173,443 | 30,395 | Oct 10, 2017, 04:39 PM |
| Deniz Yamo | Chief Medical Officer | Sep 05, 2017 | Buy | $24.20 | 1,000 | 24,200 | 9,000 | Sep 15, 2017, 05:12 PM |
| Deniz Yamo | Chief Medical Officer | Sep 01, 2017 | Buy | $24.15 | 3,000 | 72,450 | 8,000 | Sep 15, 2017, 05:12 PM |
| Deniz Yamo | Chief Medical Officer | Aug 31, 2017 | Buy | $25.40 | 1,375 | 34,925 | 5,000 | Sep 15, 2017, 05:12 PM |
| Clayman Michael D. | President and CEO | Jun 20, 2017 | Option Exercise | $15.37 | 1,243 | 19,105 | 21,389 | Jun 23, 2017, 06:36 PM |
| Stejbach Mark | Director | Jun 16, 2017 | Buy | $17.02 | 1,580 | 26,888 | 1,580 | Jun 20, 2017, 04:24 PM |
| COLELLA SAMUEL D | Director | Jun 05, 2017 | Buy | $17.01 | 5,000 | 85,048 | 5,000 | Jun 06, 2017, 06:49 PM |
| Clayman Michael D. | President and CEO | Jun 05, 2017 | Buy | $17.23 | 5,000 | 86,152 | 20,146 | Jun 06, 2017, 06:47 PM |
| Bodick Neil | Chief Medical Officer | May 15, 2017 | Option Exercise | $2.52 | 6,830 | 17,214 | 66,767 | May 19, 2017, 04:34 PM |
| Bodick Neil | Chief Medical Officer | May 15, 2017 | Sale | $18.95 | 6,830 | 129,448 | 61,637 | May 19, 2017, 04:34 PM |
| Bodick Neil | Chief Medical Officer | Apr 17, 2017 | Option Exercise | $2.52 | 5,000 | 12,601 | 64,937 | May 19, 2017, 04:32 PM |
| Bodick Neil | Chief Medical Officer | Apr 17, 2017 | Sale | $28.23 | 5,000 | 141,132 | 60,137 | May 19, 2017, 04:32 PM |
| Bodick Neil | Chief Medical Officer | Mar 17, 2017 | Option Exercise | $2.52 | 5,000 | 12,601 | 64,937 | May 19, 2017, 04:31 PM |
| Bodick Neil | Chief Medical Officer | Mar 17, 2017 | Sale | $20.41 | 5,000 | 102,038 | 59,937 | May 19, 2017, 04:31 PM |
| Bodick Neil | Chief Medical Officer | Feb 24, 2017 | Option Exercise | $2.52 | 4,000 | 10,081 | 64,937 | May 19, 2017, 04:28 PM |
| Bodick Neil | Chief Medical Officer | Feb 24, 2017 | Sale | $19.15 | 5,000 | 95,758 | 59,937 | May 19, 2017, 04:28 PM |
| Bodick Neil | Chief Medical Officer | May 15, 2017 | Sale | $18.95 | 6,830 | 129,448 | 40,807 | May 17, 2017, 04:15 PM |
| Bodick Neil | Chief Medical Officer | Apr 17, 2017 | Sale | $28.23 | 5,000 | 141,132 | 46,137 | Apr 18, 2017, 07:45 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | Mar 23, 2017 | Option Exercise | $7.89 | 3,000 | 23,658 | 10,777 | Mar 24, 2017, 04:24 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | Mar 23, 2017 | Sale | $23.00 | 3,000 | 69,000 | 7,777 | Mar 24, 2017, 04:24 PM |
| Bodick Neil | Chief Medical Officer | Mar 17, 2017 | Sale | $20.41 | 5,000 | 102,038 | 50,937 | Mar 20, 2017, 07:42 PM |
| Bodick Neil | Chief Medical Officer | Feb 24, 2017 | Sale | $19.15 | 5,000 | 95,758 | 55,937 | Feb 27, 2017, 04:17 PM |
| Bodick Neil | Chief Medical Officer | Jan 20, 2017 | Sale | $18.35 | 5,000 | 91,747 | 60,937 | Jan 23, 2017, 07:10 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | Dec 20, 2016 | Option Exercise | $9.01 | 1,134 | 10,217 | 10,531 | Dec 27, 2016, 05:00 PM |
| Clayman Michael D. | President and CEO | Dec 20, 2016 | Option Exercise | $9.01 | 147 | 1,324 | 30,868 | Dec 27, 2016, 04:58 PM |
| Bodick Neil | Chief Medical Officer | Dec 21, 2016 | Sale | $18.46 | 10,000 | 184,628 | 65,937 | Dec 22, 2016, 04:40 PM |
| COLELLA SAMUEL D | Director | Dec 01, 2016 | Buy | $16.38 | 10,000 | 163,807 | 43,333 | Dec 05, 2016, 02:40 PM |
| Clayman Michael D. | President and CEO | Nov 23, 2016 | Buy | $18.41 | 1,667 | 30,688 | 30,721 | Nov 23, 2016, 08:17 PM |
| Clayman Michael D. | President and CEO | Nov 22, 2016 | Buy | $17.95 | 1,666 | 29,900 | 29,054 | Nov 23, 2016, 08:35 AM |
| COLELLA SAMUEL D | Director | Nov 21, 2016 | Buy | $18.00 | 33,333 | 599,994 | 33,333 | Nov 22, 2016, 06:40 PM |
| Clayman Michael D. | President and CEO | Nov 21, 2016 | Buy | $17.90 | 1,666 | 29,827 | 27,388 | Nov 22, 2016, 02:28 PM |
| COLELLA SAMUEL D | Director | Jun 21, 2016 | Buy | $13.66 | 18,726 | 255,766 | 25,504 | Jun 22, 2016, 01:36 PM |
| COLELLA SAMUEL D | Director | Jun 20, 2016 | Buy | $13.84 | 6,778 | 93,833 | 6,778 | Jun 22, 2016, 01:36 PM |
| MERRIFIELD C ANN | Director | Jun 14, 2016 | Buy | $13.39 | 1,000 | 13,387 | 2,000 | Jun 16, 2016, 05:59 PM |
| LUBASH BARBARA N | 10% Owner | Jun 08, 2016 | Buy | $14.00 | 714,285 | 9,999,990 | 3,511,670 | Jun 10, 2016, 09:40 PM |
| Versant Ventures III, LLC | 10% Owner | Jun 08, 2016 | Buy | $14.00 | 714,285 | 9,999,990 | 3,511,670 | Jun 10, 2016, 09:16 PM |
| COLELLA SAMUEL D | Director | Jun 08, 2016 | Buy | $14.00 | 714,285 | 9,999,990 | 3,511,670 | Jun 10, 2016, 08:25 PM |
| Clayman Michael D. | President and CEO | May 23, 2016 | Option Exercise | $0.16 | 10,369 | 1,686 | 25,722 | May 24, 2016, 05:26 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | May 20, 2016 | Option Exercise | $8.92 | 963 | 8,590 | 9,397 | May 24, 2016, 05:25 PM |
| Clayman Michael D. | President and CEO | May 20, 2016 | Buy | $10.41 | 2,000 | 20,810 | 13,568 | May 23, 2016, 04:04 PM |
| Clayman Michael D. | President and CEO | May 19, 2016 | Buy | $9.65 | 2,000 | 19,297 | 11,568 | May 20, 2016, 05:52 PM |
| Bodick Neil | Chief Medical Officer | May 19, 2016 | Buy | $10.00 | 850 | 8,500 | 75,937 | May 20, 2016, 05:51 PM |
| Clayman Michael D. | President and CEO | May 18, 2016 | Buy | $10.23 | 2,000 | 20,465 | 9,568 | May 19, 2016, 05:30 PM |
| Bodick Neil | Chief Medical Officer | May 18, 2016 | Buy | $10.20 | 2,100 | 21,420 | 75,087 | May 19, 2016, 05:29 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | May 17, 2016 | Buy | $9.87 | 2,500 | 24,668 | 8,434 | May 18, 2016, 05:23 PM |
| Clayman Michael D. | President and CEO | May 17, 2016 | Buy | $9.73 | 2,000 | 19,465 | 7,568 | May 18, 2016, 05:22 PM |
| Bodick Neil | Chief Medical Officer | May 17, 2016 | Buy | $9.60 | 800 | 7,680 | 72,987 | May 18, 2016, 05:21 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | May 16, 2016 | Buy | $9.19 | 2,500 | 22,972 | 5,934 | May 17, 2016, 06:12 PM |
| Clayman Michael D. | President and CEO | May 16, 2016 | Buy | $9.51 | 2,000 | 19,025 | 5,568 | May 17, 2016, 06:10 PM |
| Bodick Neil | Chief Medical Officer | May 16, 2016 | Buy | $9.22 | 1,250 | 11,525 | 72,187 | May 17, 2016, 06:08 PM |
| MERRIFIELD C ANN | Director | Sep 11, 2015 | Buy | $23.00 | 1,000 | 23,000 | 1,000 | Sep 14, 2015, 04:32 PM |
| Novo A/S | 10% Owner | Jun 22, 2015 | Sale | $20.55 | 63,412 | 1,302,844 | 2,133,131 | Jun 22, 2015, 06:22 PM |
| Novo A/S | 10% Owner | Jun 19, 2015 | Sale | $20.07 | 50,888 | 1,021,225 | 2,196,543 | Jun 22, 2015, 06:22 PM |
| Novo A/S | 10% Owner | Jun 18, 2015 | Sale | $21.51 | 35,700 | 767,903 | 2,247,431 | Jun 22, 2015, 06:22 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | May 20, 2015 | Option Exercise | $11.91 | 1,311 | 15,614 | 2,754 | May 27, 2015, 03:10 PM |
| Clayman Michael D. | President and CEO | May 20, 2015 | Option Exercise | $11.91 | 1,784 | 21,247 | 282,229 | May 27, 2015, 03:07 PM |
| Clayman Michael D. | President and CEO | Mar 24, 2015 | Option Exercise | $0.16 | 5,000 | 813 | 280,445 | Mar 25, 2015, 04:01 PM |
| Bodick Neil | Chief Medical Officer | Mar 16, 2015 | Sale | $25.28 | 4,000 | 101,115 | 72,437 | Mar 16, 2015, 05:19 PM |
| Bodick Neil | Chief Medical Officer | Mar 10, 2015 | Sale | $24.26 | 4,000 | 97,055 | 74,937 | Mar 11, 2015, 02:22 PM |
| Bodick Neil | Chief Medical Officer | Mar 04, 2015 | Sale | $23.45 | 4,000 | 93,790 | 78,937 | Mar 05, 2015, 08:50 PM |
| Bodick Neil | Chief Medical Officer | Feb 26, 2015 | Sale | $22.44 | 4,000 | 89,766 | 82,937 | Feb 26, 2015, 08:25 PM |
| Sofinnova Partners SAS | 10% Owner | Oct 29, 2014 | Sale | $20.00 | 10,000 | 200,000 | 2,095,491 | Jan 22, 2015, 02:02 PM |
| Novo A/S | 10% Owner | Dec 17, 2014 | Buy | $17.00 | 500,000 | 8,500,000 | 2,283,131 | Dec 18, 2014, 03:44 PM |
| DRISCOLL FREDERICK W | Chief Financial Officer | Nov 20, 2014 | Option Exercise | $11.91 | 1,443 | 17,186 | 1,443 | Nov 26, 2014, 05:16 PM |
| Clayman Michael D. | President and CEO | Nov 20, 2014 | Option Exercise | $11.91 | 1,784 | 21,247 | 275,445 | Nov 26, 2014, 05:15 PM |
| Versant Venture Capital III, L.P. | Director | Sep 10, 2014 | Option Exercise | $17.61 | 2,250 | 39,623 | 2,250 | Sep 12, 2014, 09:00 PM |
| Versant Venture Capital III, L.P. | Director | Sep 10, 2014 | Option Exercise | $17.61 | 2,250 | 39,623 | 2,250 | Sep 12, 2014, 08:13 PM |
| Novo A/S | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 692,308 | 9,000,004 | 1,783,131 | Feb 20, 2014, 05:11 PM |
| Versant Venture Capital III, L.P. | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 305,886 | 3,976,518 | 3,205,001 | Feb 20, 2014, 03:01 PM |
| Versant Venture Capital III, L.P. | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 1,806 | 23,478 | 3,206,807 | Feb 20, 2014, 03:01 PM |
| Tordjman Rafael | Director | Feb 18, 2014 | Buy | $13.00 | 230,769 | 2,999,997 | 2,105,491 | Feb 20, 2014, 03:00 PM |
| Sofinnova Partners SAS | 10% Owner | Feb 18, 2014 | Buy | $13.00 | 230,769 | 2,999,997 | 2,105,491 | Feb 20, 2014, 02:59 PM |
| COLELLA SAMUEL D | Director | Feb 18, 2014 | Buy | $13.00 | 307,692 | 3,999,996 | 3,206,807 | Feb 20, 2014, 02:50 PM |
| Bolzon Bradley J PhD | Director | Feb 18, 2014 | Buy | $13.00 | 307,692 | 3,999,996 | 3,206,807 | Feb 20, 2014, 02:46 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Stejbach Mark | Director | 11/19/2021 | 107,364 |
| MILINAZZO ALAN | Director | 11/19/2021 | 233,325 |
| MERRIFIELD C ANN | Director | 11/19/2021 | 161,500 |
| Lukatch Heath | Director | 11/19/2021 | 76,500 |
| Kwo Elizabeth | Director | 11/19/2021 | 38,250 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 76,500 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 3,303,806 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 49,904 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 8,450,097 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 42,500 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 2,125 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 612,298 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 167,051 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 8,500 |
| COLELLA SAMUEL D | Director | 11/19/2021 | 8,016 |
| Canute Scott A | Director | 11/19/2021 | 76,500 |
| MAHAFFY PATRICK J | Director | 11/19/2021 | 338,504 |
| Levine Mark S. | General Counsel | 11/19/2021 | 1,134,631 |
| Muzikant Adam | Chief Business Officer | 11/19/2021 | 881,161 |
| Wentworth Kerry | Chief Regulatory Officer | 11/19/2021 | 1,197,166 |
| Wentworth Kerry | Chief Regulatory Officer | 11/19/2021 | 51,000 |
| Layman Melissa | Chief Commercial Officer | 11/19/2021 | 883,626 |
| Willwerth Christina | Chief Strategy Officer | 11/19/2021 | 1,200,549 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 11/19/2021 | 260,780 |
| Andrews William T. | Chief Medical Officer | 11/19/2021 | 291,125 |
| Clayman Michael D. | President and CEO | 11/19/2021 | 3,303,806 |
| Clayman Michael D. | President and CEO | 11/19/2021 | 209,100 |
| Clayman Michael D. | President and CEO | 11/19/2021 | 3,177,037 |
| Clayman Michael D. | President and CEO | 11/19/2021 | 2,851,733 |
| Willwerth Christina | Chief Strategy Officer | 07/19/2021 | 25,445 |
| Wentworth Kerry | Chief Regulatory Officer | 07/19/2021 | 25,439 |
| Muzikant Adam | Chief Business Officer | 07/19/2021 | 12,061 |
| Levine Mark S. | General Counsel | 07/19/2021 | 25,445 |
| Muzikant Adam | Chief Business Officer | 06/21/2021 | 16,190 |
| Wentworth Kerry | Chief Regulatory Officer | 06/21/2021 | 4,193 |
| Clayman Michael D. | President and CEO | 06/21/2021 | 13,226 |
| Arkowitz David | Chief Financial Officer | 05/10/2021 | 16,116 |
| Layman Melissa | Chief Commercial Officer | 03/15/2021 | 53,336 |
| Layman Melissa | Chief Commercial Officer | 01/28/2021 | 32,931 |
| Clayman Michael D. | President and CEO | 01/28/2021 | 108,559 |
| Muzikant Adam | Chief Business Officer | 01/05/2021 | 44,576 |
| KELLEY SCOTT | Chief Medical Officer | 01/05/2021 | 76,007 |
| Wentworth Kerry | Chief Regulatory Officer | 01/05/2021 | 76,007 |
| Willwerth Christina | Chief Strategy Officer | 01/05/2021 | 73,480 |
| Levine Mark S. | General Counsel | 01/05/2021 | 76,007 |
| Arkowitz David | Chief Financial Officer | 01/05/2021 | 67,592 |
| MILINAZZO ALAN | Director | 07/09/2020 | 40,500 |
| Arkowitz David | Chief Financial Officer | 06/22/2020 | 14,111 |
| Clayman Michael D. | President and CEO | 06/22/2020 | 14,111 |
| KELLEY SCOTT | Chief Medical Officer | 06/22/2020 | 6,444 |
| Levine Mark S. | General Counsel | 06/22/2020 | 11,079 |
| Wentworth Kerry | Chief Regulatory Officer | 06/22/2020 | 3,996 |
| Stejbach Mark | Director | 05/26/2020 | 19,997 |
| Clayman Michael D. | President and CEO | 05/26/2020 | 99,996 |
| Arkowitz David | Chief Financial Officer | 05/07/2020 | 26,253 |
| Willwerth Christina | Chief Strategy Officer | 10/07/2019 | 14,008 |
| Wentworth Kerry | Chief Regulatory Officer | 10/07/2019 | 14,008 |
| Clayman Michael D. | President and CEO | 10/07/2019 | 61,540 |
| KELLEY SCOTT | Chief Medical Officer | 10/07/2019 | 4,669 |
| Bodick Neil | Chief Scientific Officer | 10/07/2019 | 18,817 |
| MAHAFFY PATRICK J | Director | 08/29/2019 | 4,932 |
| Willwerth Christina | Chief Strategy Officer | 08/13/2019 | 1,400 |
| COLELLA SAMUEL D | Director | 08/08/2019 | 21,480 |
| Clayman Michael D. | President and CEO | 08/08/2019 | 25,136 |
| Clayman Michael D. | President and CEO | 06/21/2019 | 14,637 |
| Levine Mark S. | General Counsel | 06/21/2019 | 11,900 |
| Wentworth Kerry | Chief Regulatory Officer | 06/21/2019 | 3,816 |
| KELLEY SCOTT | Chief Medical Officer | 06/21/2019 | 21,111 |
| Arkowitz David | Chief Financial Officer | 06/21/2019 | 21,111 |
| Arkowitz David | Chief Financial Officer | 05/31/2019 | 27,627 |
| MERRIFIELD C ANN | Director | 05/23/2019 | 101,120 |
| Arkowitz David | Chief Financial Officer | 05/13/2019 | 47,960 |
| Clayman Michael D. | President and CEO | 05/10/2019 | 50,067 |
| Arkowitz David | Chief Financial Officer | 05/08/2019 | 22,615 |
| Clayman Michael D. | President and CEO | 03/12/2019 | 50,009 |
| Wentworth Kerry | Chief Regulatory Officer | 10/08/2018 | 18,637 |
| Levine Mark S. | General Counsel | 01/03/2019 | 9,072 |
| Wentworth Kerry | Chief Regulatory Officer | 01/03/2019 | 7,688 |
| KELLEY SCOTT | Chief Medical Officer | 01/03/2019 | 7,688 |
| Arkowitz David | Chief Financial Officer | 12/20/2018 | 9,663 |
| Bodick Neil | Chief Scientific Officer | 01/03/2019 | 9,221 |
| Clayman Michael D. | President and CEO | 01/03/2019 | 40,516 |
| Clayman Michael D. | President and CEO | 11/09/2018 | 85,477 |
| Arkowitz David | Chief Financial Officer | 11/09/2018 | 66,222 |
| Bodick Neil | Chief Scientific Officer | 10/08/2018 | 25,017 |
| Clayman Michael D. | President and CEO | 10/08/2018 | 115,934 |
| Wentworth Kerry | Chief Regulatory Officer | 10/08/2018 | 18,637 |
| Arkowitz David | Chief Financial Officer | 08/09/2018 | 93,680 |
| Clayman Michael D. | President and CEO | 08/09/2018 | 223,300 |
| Bodick Neil | Chief Scientific Officer | 07/02/2018 | 841,192 |
| Bodick Neil | Chief Scientific Officer | 07/03/2018 | 412,300 |
| Wentworth Kerry | Chief Regulatory Officer | 06/20/2018 | 3,629 |
| KELLEY SCOTT | Chief Medical Officer | 06/20/2018 | 21,241 |
| Clayman Michael D. | President and CEO | 06/20/2018 | 11,756 |
| Levine Mark S. | General Counsel | 06/20/2018 | 11,438 |
| Bodick Neil | Chief Scientific Officer | 05/11/2018 | 6,130 |
| Clayman Michael D. | President and CEO | 12/20/2017 | 2,754 |
| KELLEY SCOTT | Chief Medical Officer | 12/20/2017 | 14,234 |
| Bodick Neil | Chief Scientific Officer | 11/21/2017 | 24,656 |
| Bodick Neil | Chief Scientific Officer | 11/21/2017 | 41,457 |
| Clayman Michael D. | President and CEO | 11/08/2017 | 118,000 |
| Bodick Neil | Chief Scientific Officer | 10/06/2017 | 47,835 |
| Clayman Michael D. | President and CEO | 10/06/2017 | 173,443 |
| Deniz Yamo | Chief Medical Officer | 09/05/2017 | 24,200 |
| Deniz Yamo | Chief Medical Officer | 09/01/2017 | 72,450 |
| Deniz Yamo | Chief Medical Officer | 08/31/2017 | 34,925 |
| Clayman Michael D. | President and CEO | 06/20/2017 | 19,105 |
| Stejbach Mark | Director | 06/16/2017 | 26,888 |
| COLELLA SAMUEL D | Director | 06/05/2017 | 85,048 |
| Clayman Michael D. | President and CEO | 06/05/2017 | 86,152 |
| Bodick Neil | Chief Medical Officer | 05/15/2017 | 17,214 |
| Bodick Neil | Chief Medical Officer | 05/15/2017 | 129,448 |
| Bodick Neil | Chief Medical Officer | 04/17/2017 | 12,601 |
| Bodick Neil | Chief Medical Officer | 04/17/2017 | 141,132 |
| Bodick Neil | Chief Medical Officer | 03/17/2017 | 12,601 |
| Bodick Neil | Chief Medical Officer | 03/17/2017 | 102,038 |
| Bodick Neil | Chief Medical Officer | 02/24/2017 | 10,081 |
| Bodick Neil | Chief Medical Officer | 02/24/2017 | 95,758 |
| Bodick Neil | Chief Medical Officer | 05/15/2017 | 129,448 |
| Bodick Neil | Chief Medical Officer | 04/17/2017 | 141,132 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 03/23/2017 | 23,658 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 03/23/2017 | 69,000 |
| Bodick Neil | Chief Medical Officer | 03/17/2017 | 102,038 |
| Bodick Neil | Chief Medical Officer | 02/24/2017 | 95,758 |
| Bodick Neil | Chief Medical Officer | 01/20/2017 | 91,747 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 12/20/2016 | 10,217 |
| Clayman Michael D. | President and CEO | 12/20/2016 | 1,324 |
| Bodick Neil | Chief Medical Officer | 12/21/2016 | 184,628 |
| COLELLA SAMUEL D | Director | 12/01/2016 | 163,807 |
| Clayman Michael D. | President and CEO | 11/23/2016 | 30,688 |
| Clayman Michael D. | President and CEO | 11/22/2016 | 29,900 |
| COLELLA SAMUEL D | Director | 11/21/2016 | 599,994 |
| Clayman Michael D. | President and CEO | 11/21/2016 | 29,827 |
| COLELLA SAMUEL D | Director | 06/21/2016 | 255,766 |
| COLELLA SAMUEL D | Director | 06/20/2016 | 93,833 |
| MERRIFIELD C ANN | Director | 06/14/2016 | 13,387 |
| LUBASH BARBARA N | 10% Owner | 06/08/2016 | 9,999,990 |
| Versant Ventures III, LLC | 10% Owner | 06/08/2016 | 9,999,990 |
| COLELLA SAMUEL D | Director | 06/08/2016 | 9,999,990 |
| Clayman Michael D. | President and CEO | 05/23/2016 | 1,686 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 05/20/2016 | 8,590 |
| Clayman Michael D. | President and CEO | 05/20/2016 | 20,810 |
| Clayman Michael D. | President and CEO | 05/19/2016 | 19,297 |
| Bodick Neil | Chief Medical Officer | 05/19/2016 | 8,500 |
| Clayman Michael D. | President and CEO | 05/18/2016 | 20,465 |
| Bodick Neil | Chief Medical Officer | 05/18/2016 | 21,420 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 05/17/2016 | 24,668 |
| Clayman Michael D. | President and CEO | 05/17/2016 | 19,465 |
| Bodick Neil | Chief Medical Officer | 05/17/2016 | 7,680 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 05/16/2016 | 22,972 |
| Clayman Michael D. | President and CEO | 05/16/2016 | 19,025 |
| Bodick Neil | Chief Medical Officer | 05/16/2016 | 11,525 |
| MERRIFIELD C ANN | Director | 09/11/2015 | 23,000 |
| Novo A/S | 10% Owner | 06/22/2015 | 1,302,844 |
| Novo A/S | 10% Owner | 06/19/2015 | 1,021,225 |
| Novo A/S | 10% Owner | 06/18/2015 | 767,903 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 05/20/2015 | 15,614 |
| Clayman Michael D. | President and CEO | 05/20/2015 | 21,247 |
| Clayman Michael D. | President and CEO | 03/24/2015 | 813 |
| Bodick Neil | Chief Medical Officer | 03/16/2015 | 101,115 |
| Bodick Neil | Chief Medical Officer | 03/10/2015 | 97,055 |
| Bodick Neil | Chief Medical Officer | 03/04/2015 | 93,790 |
| Bodick Neil | Chief Medical Officer | 02/26/2015 | 89,766 |
| Sofinnova Partners SAS | 10% Owner | 10/29/2014 | 200,000 |
| Novo A/S | 10% Owner | 12/17/2014 | 8,500,000 |
| DRISCOLL FREDERICK W | Chief Financial Officer | 11/20/2014 | 17,186 |
| Clayman Michael D. | President and CEO | 11/20/2014 | 21,247 |
| Versant Venture Capital III, L.P. | Director | 09/10/2014 | 39,623 |
| Versant Venture Capital III, L.P. | Director | 09/10/2014 | 39,623 |
| Novo A/S | 10% Owner | 02/18/2014 | 9,000,004 |
| Versant Venture Capital III, L.P. | 10% Owner | 02/18/2014 | 3,976,518 |
| Versant Venture Capital III, L.P. | 10% Owner | 02/18/2014 | 23,478 |
| Tordjman Rafael | Director | 02/18/2014 | 2,999,997 |
| Sofinnova Partners SAS | 10% Owner | 02/18/2014 | 2,999,997 |
| COLELLA SAMUEL D | Director | 02/18/2014 | 3,999,996 |
| Bolzon Bradley J PhD | Director | 02/18/2014 | 3,999,996 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR FLEXION THERAPEUTICS INC
LOADING...